Podcasts about ozempic

Could Ozempic slow—or even reverse—aging? We take a closer look at the science behind the buzzy headlines.References:Semaglutide Slows Epigenetic Aging in People with HIV-associated lipohypertrophy: Evidence from a Randomized Controlled Trial | medRxiv  [pre-print]Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial - PubMedFind a full transcript here. New to Nutrition Diva? Check out our special Spotify playlist for a collection of the best episodes curated by our team and Monica herself! We've also curated some great playlists on specific episode topics including Staying Strong as We Age, Diabetes, Weight Loss That Lasts and Gut Health! Also, find a playlist of our bone health series, Stronger Bones at Every Age. Have a nutrition question? Send an email to nutrition@quickanddirtytips.com.Follow Nutrition Diva on Facebook and subscribe to the newsletter for more diet and nutrition tips. Find out about Monica's keynotes and other programs at WellnessWorksHere.comNutrition Diva is a part of the Quick and Dirty Tips podcast network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textWhat if everything you thought you knew about weight loss was wrong? In this powerful conversation, Joey Pinz sits down with Dr. David Plourdé—scientist, author of Solving the Weight Loss Puzzle, and founder of The Plourde Method—to uncover the real science behind lasting fat loss.Dr. Plourdé shares insights from 34 years in the lab, where he studied fat cells, food addiction, and the hidden forces sabotaging our health. From uncovering insidious carbs in everyday foods to exposing the dark side of weight-loss drugs like Ozempic, his revelations will make you rethink nutrition, exercise, and the role of psychology in transformation.✨ Top 3 Highlights:

GLP-1 has been making headlines thanks to weight loss medications like Ozempic and Wegovy—but here's the thing: your body already makes GLP-1 naturally. This powerful gut hormone plays a key role in satiety, blood sugar balance, and metabolic health.In this episode, I break down:What GLP-1 is and how your body makes itThe foods and lifestyle habits that naturally support GLP-1 productionThe fascinating role of gut bacteria—like Akkermansia muciniphila and Clostridium butyricum—in lowering inflammation and improving metabolic functionMetabolic daily probiotic linked in my FullscriptWhy GLP-1 is about more than just weight loss, and how it ties into energy, digestion, and long-term healthIf you've been curious about natural ways to support your metabolism, gut health, and energy (without chasing quick fixes), this episode will give you practical, root-cause strategies you can start using today.✨ Takeaway: You don't need to rely on injections—your body is designed to make GLP-1 when you give it the right inputs.

❓ Can non-surgical skin tightening really replace a facelift? Can lasers erase scars or stretch marks? What about cellulite treatments—do they actually work?In this episode of Plastic Surgery Uncensored, Beverly Hills board-certified plastic surgeon Dr. Rady Rahban exposes the four biggest myths in plastic surgery—the trillion-dollar “snake oil” promises that have fooled millions of patients.Here's what you'll learn:✨ Non-surgical skin tightening – Why no machine can replicate surgery.✨ Scar removal lasers & creams – The truth about scar quality and what really makes scars nearly invisible.✨ Cellulite treatments – The disappointing reality behind devices and injections.✨ Stretch mark removal – Why nothing erases them—and what camouflage techniques actually help.Dr. Rahban explains why these myths persist, how aggressive marketing tricks patients, and why—if these treatments actually worked—they'd be as undeniable as Botox or Ozempic.

I'm leaving for my yearly Disney trip for the T1D conference, and y'all — nothing will humble you more than a three-way dressing-room mirror. I tried on one of those athletic dresses and BAM: back-fat in the mirror I'd never noticed before. Cue the body image vacation panic. But I refused to let bad lighting and spandex steal my trip. In this episode, I tell the whole embarrassing story, exactly how I knocked myself out of that spiral, and why you absolutely cannot put your life on hold until the scale says so.

AI accelerates drug discovery while steroids turn teens into aggressive strangers. Dr. Michael Israetel explores our pharmaceutical crossroads here!Full show notes and resources can be found here: jordanharbinger.com/1209What We Discuss with Michael Israetel:GLP-1 drugs like Tirzepatide offer massive health benefits beyond weight loss — reducing inflammation, improving brain health, and decreasing addiction behaviors, even for people already in good shape.Steroids don't just amplify personality — they specifically amplify masculine traits like aggression and reduce empathy. Starting young can permanently rewire your brain's emotional and social processing.AI is about to revolutionize medicine by testing millions of drug candidates virtually, creating treatments 10x more effective with 10x fewer side effects. We're entering the pharmaceutical iPhone moment.The "only take drugs when sick" mindset worked in the 20th century, but is becoming dangerously outdated — like refusing elevators because you prefer human operators.When your diet plateaus, take a week-long break eating at maintenance. Your stress hormones will drop, body water will flush out, and you'll often look leaner than before.And much more...And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:Saily: 15% off: saily.com/jordanharbinger, code JORDANHARBINGERDripDrop: 20% off: DripDrop.com, code JORDANLinkedIn Jobs: Post your job for free: linkedin.com/jordanQuince: Free shipping & 365-day returns: quince.com/jordanBetterHelp: 10% off first month: betterhelp.com/jordanSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

To read more of Derek's reporting on GLP-1 drugs, you can subscribe to his Substack here. GLP-1 drugs like Ozempic and Zepbound don't just help with Type 2 diabetes and weight loss. They seem to curb alcohol, cocaine, and tobacco use among addicts. In some studies, they prevent strokes, heart attacks, chronic kidney disease, sleep apnea, and Parkinson's disease. They're associated with a lower risk of several cancers, including pancreatic cancer and multiple myeloma. Arthritic patients on the drugs experienced relief from knee pain that was “on par with opioid drugs.” A small study found that they reduce migraine headaches by 50 percent. And emerging research suggests they might even slow the rate of memory loss among people diagnosed with Alzheimer's. Is all of this real? And if it's real, how is one drug doing so many different things? And if it is doing all those things, why shouldn't we be developing versions of the drug for just about everyone? Today we have two guests: David D'Alessio, chief of endocrinology and metabolism at the Duke University School of Medicine; and Randy Seeley, a professor of surgery, internal medicine, and nutritional sciences at the University of Michigan. We talk about how these drugs work—why they seem to do everything—and how our understanding of them could make them better, more effective, more broadly useful. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: David D'Alessio and Randy Seeley Producer: Devon Baroldi Disclosure: Dr. Seeley has received research support from several pharmaceutical companies, including Eli Lilly, Diasome, and Amgen. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week we sit down with Dr. Kiran Mian, yes, Alix Earle's derm and one of NYC's most in-demand board-certified dermatologists, for a no-BS conversation on all things skin. From acne at every age to the rise of “Ozempic face,” Dr. Mian breaks down what really works (and what doesn't), the filler mistakes women keep making, why less is more, and the treatments worth your money. We also dive into the chaotic world of TikTok skincare trends, how overconsumption is secretly aging you, and why fall is officially laser season for resetting texture and tone. Chic, science-backed, and refreshingly honest, Dr. Mian shares the expert tips you need to feel confident in your own skin. Mentioned in the Episode:  YSE BEAUTY Your Favorite Ex Exfoliating Pads Oral Spironolacton Winlevi Topical Benzoyl Peroxide Salicylic Acid Face Cleanser Accutane YSE Beauty DIEUX Deliverance Serum Medik8 C-Tetra Serum IOPE Vitamin C Expert 25% Antioxidant Toning Serum MAISON FRANCIS KURKDJIAN Apom Eau de Parfum HOURGLASS Veil Hydrating Skin Tint HOURGLASS Vanish Airbrush Concealer A Sony Music Entertainment production.  Find more great podcasts from Sony Music Entertainment at sonymusic.com/podcasts and follow us at @sonypodcasts  To bring your brand to life in this podcast, email podcastadsales@sonymusic.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, Shana Hussin, RDN, shares the replay of her recent webinar on GLP-1 — the hormone behind today's most popular weight loss drugs like Ozempic, Wegovy, and Mounjaro. You'll learn: ✔️ What GLP-1 is and how it works in the body ✔️ Natural ways to increase GLP-1 for fewer cravings, better blood sugar, and fat loss ✔️ Lifestyle habits that decrease GLP-1 and fuel insulin resistance ✔️ The truth about GLP-1 medications: cost, side effects, and sustainability ✔️ How to safely transition off GLP-1 drugs by improving natural GLP-1 and gut health ✔️ The research behind Unimate Yerba Mate and Balance Fiber Matrix — and how they support GLP-1 signaling in the Feel Great System ✨ If you've ever wondered whether you really need expensive GLP-1 medications, or if there's a more sustainable, root-cause solution, this episode is for you. Resources & Links:

Why your nervous system — not your willpower — is the key to healing stress, burnout, and sleep struggles. This week, I'm joined by Povilas Sabaliauskas, CEO and co-founder of Pulsetto (code: BIOHACKINGBRITTANY), to talk about how regulating the vagus nerve can change the way we respond to stress, burnout, and even sleep struggles. We explore how Povilas' journey led to creating Pulsetto, a vagus nerve device that resets the body in minutes. We also unpack neuromodulation, the differences between stress, anxiety, and burnout, and how HRV tracking reveals your nervous system health. This is a must-listen for anyone juggling the demands of modern life, especially parents and women navigating constant stressors. WE TALK ABOUT:  11:00 – How personal loss led Povilas to explore neuromodulation and nervous system health 18:00 – What vagus nerve stimulation is and why it matters for stress and relaxation 21:00 – The hidden addiction to adrenaline and overstimulation 24:30 – Social media, dopamine, and the junk food of the brain 28:40 – Differentiating between stress, anxiety, and burnout 33:45 – How Pulsetto impacts HRV and sleep quality 43:15 – How Pulsetto compares to other neuromodulation devices 48:40 – Potential applications in pain management, from tattoos to labor 52:45 – The optimal daily routine for using Pulsetto SPONSORS: CaloCurb (get 10% OFF) is my go-to, 100% plant-based alternative to Ozempic—helping you feel full sooner, snack less, and finally trust your body again without needles, drugs, or yo-yo diets. Join me in Costa Rica for Optimize Her, a 5-night luxury women's retreat in Costa Rica with yoga, healing rituals, and biohacking workshops—only 12 spots available. RESOURCES: Trying to conceive? Join my Baby Steps Course to optimize your fertility with biohacking. Free gift: Download my hormone-balancing, fertility-boosting chocolate recipe. Explore my luxury retreats and wellness events for women. Shop my faves: Check out my Amazon storefront for wellness essentials. Pulsetto's website (code: BIOHACKINGBRITTANY) and Instagram LET'S CONNECT: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, YouTube Music

GLP-1 agonists are transforming medicine in ways few could have predicted. In this captivating conversation, naturopathic physician Dr. Tina Moore challenges the conventional narrative around these medications, revealing their potential beyond weight loss and diabetes management.When Dr. Tina first began researching GLP-1s, she discovered a wealth of overlooked studies showing profound effects on inflammation, autoimmunity, and regenerative healing. Despite facing significant pushback from colleagues who expected a naturopathic doctor to reject pharmaceutical interventions, she couldn't ignore the compelling evidence. What she found most remarkable was how these peptides—which naturally occur in our bodies—could address multiple health issues simultaneously through their "pleiotropic" effects.The conversation ventures into territory rarely discussed in mainstream medical circles: how lower, personalized doses might provide optimal benefits while minimizing side effects. Dr. Tina shares striking clinical observations, including her own experience with Hashimoto's thyroiditis improving dramatically on a micro-dose regimen. Patients report unexpected improvements in conditions ranging from rheumatoid arthritis to depression to addictive behaviors—benefits that appear independent of weight loss.Most fascinating is Dr. Tina's perspective on dosing strategy. While conventional protocols typically start higher and escalate quickly, this approach risks receptor desensitization and excessive AMPK pathway activation, potentially causing disproportionate muscle loss. She advocates for "slow and low" dosing, tailored to individual needs, working alongside comprehensive lifestyle changes.The discussion also tackles accessibility issues, comparing compounded options with brand-name medications, and speculates about future developments that might make these treatments more affordable and personalized. If you're curious about metabolic health, inflammation, or the future of medicine, this conversation offers a refreshingly nuanced perspective that cuts through polarized debates with evidence-based insights.https://www.drtyna.com/https://www.gatlan.com/Lies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/Complete Metabolic Heart Scan (LUFKIN20 for 20% off) https://www.innerscopic.com/Fasting Mimicking Diet (20% off) https://prolonlife.com/Lufkin At home blood testing (20% off) https://siphoxhealth.com/lufkinMimio Health (LUFKIN for 15% off) https://mimiohealth.sjv.io/c/5810114/2745519/30611 Web: https://robertlufkinmd.com/X: https://x.com/robertlufkinmdYoutube: https://www.youtube.com/robertLufkinmdInstagram: https://www.instagram.com/robertlufkinmd/LinkedIn: https://www.linkedin.com/in/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinThreads: https://www.threads.net/@robertlufkinmdFacebook: ...

In this “Just the Babes” episode, we're diving into the latest health headlines regarding GLP-1s & Ozempic teeth, microplastics, "Soft Clubbing", and Gen Z's alcohol downtrend. We share some of the biohacks we've been experimenting with lately, and also open up about surgery and injury recovery—what's been working, what hasn't, and the lessons we're learning along the way. While we love exploring new tools and tech, we keep coming back to the reminder that the best biohacks are free, simple, and accessible to everyone. Think sunlight, breath, sleep, movement, and hydration—these are the true foundations that make everything else work better. We break down how these practices show up in our own lives and why they're essential for long-term resilience and vitality.SHOW NOTES:0:39 Welcome to the show!3:24 Alcohol consumption5:59 Better mocktails8:24 “Soft Clubbing”11:45 Microplastics15:34 Renee's travel tips17:44 Ozempic teeth21:12 Support while on a GLP-122:42 Renee's surgery recovery28:32 Peptides for healing30:48 Lauren's injury recovery37:00 HRV Biofeedback38:31 Our top biohacks for you40:08 Grounding shoes42:19 Sun exposure44:22 Sleep hygiene51:29 Fasting54:10 Exercise vs Movement56:21 Upcoming Events56:49 Thanks for tuning in!RESOURCES:New Brew - code: BHBABES24Mycology PsychologyOptimal HRV (HRV Biofeedback)Eight Sleep - code: BIOHACKERBABESMimio - code: BIOHACKERBABESEp 304: Sober Lifestyle with Amanda KudaEp 301: Mimio Fasting with Dr. Chris RhodesEVENTS:Ultimate Wellness in Miami, FL - code: BIOHACKERBABESHealthspan Summit in Los Angeles, CA - code: BIOHACKERBABESHack Your Health in Tampa, FL - code: BIOHACKERBABESSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

On this week's Spectator Out Loud: James Heale reports on the battle for the north; Robert Hardman provides his royal notebook; who's really in charge of China, asks Francis Pike; Henrietta Harding goes on Ozempic safari; and, Mary Wakefield explains how to raise a patriot.Produced and presented by Patrick Gibbons. Hosted on Acast. See acast.com/privacy for more information.

Laura Dowling (The Fabulous Pharmacist online) is an entrepreneur, pharmacist, scientist and founder of fabU.  She qualified as pharmacist and scientist, having graduated from Trinity College Dublin in 2002, with over 20 years of professional experience in community pharmacy. Her lifetime dedication to the industry was recognised when she was awarded the prestigious 2022 Pharmacist of the Year Award. This was a very wide-ranging podcast covering so many different topics.  We record in person too; so, the full video is available on my YouTube channel Brian Keane Fitness if you prefer to watch your podcasts.  Enjoy this diverse conversation with a wonderful human being.    Watch on YouTube:  https://www.youtube.com/@BrianKeaneFitness     Today's podcast is sponsored by The Circle (my online group business coaching mastermind) https://briankeanefitness.com/online-mastermind     You can listen to my appearance on Laura's show here.  https://www.youtube.com/watch?v=hL3663US-_o     (Website) fabÜ nutritional supplements (Instagram) www.instagram.com/fabulouspharmacist/   (Youtube) Laura Dowling - YouTube (Spotify) The Laura Dowling Experience | Podcast on Spotify (Wellness Blog) fabuwellness.com/blogs/wellness-blog Laura's new book:  https://www.easons.com/love-your-vulva-laura-dowling-9781836884248?srsltid=AfmBOop8uLN_0wMXjaszP2qwQGONdH7MDLbPgt8SC7DH2Zdafr9qzQuG  

This week, we're diving into The Cut's article on the rise of the “forever-35 face” and the trend of undetectable facelifts. We break down the difference between SMAS and deep-plane techniques, why more women are turning to surgery earlier, and how treatments like CO₂ lasers, Morpheus8, and other non-surgical options are reshaping what it means to “age well.” From fillers falling out of favor to the influence of Ozempic and celebrity culture, we're asking: is this new era of beauty empowerment, or just another impossible standard wrapped in a softer package?---Stream Hannah's album, PHASES!Watch Emily's Short Film, All We Were!Emily's TikTok ShopEmily's Substack: third martini thoughts---Emily's Captivation: The Gilded AgeHannah's Captivation: Lesser Evil Pumpkin Spice PopcornShop CLEARSTEM and 15% off with the code GALSGUIDE at checkout---Welcome to The Gal's Guide — a weekly dating and lifestyle podcast created to empower radical self-love and bold relationships. Join us, long-distance best friends Hannah Adams and Emily Aleece Burton, for amusing and vulnerable conversations with insightful guests as we cover topics like love and dating to your own self-love, healing, spirituality, and always remembering the importance of gal pals. Want to request a topic or work with us? Send us an email at hello@thegalsguidepod.com or visit us on our website at thegalsguidepod.com---FOLLOW US!Instagram: @thegalsguidepodSecret Facebook Group: The Gal ScoutsEmily: @emilyaleeceHannah: @hannahadamsmillerAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Spätestens seit dem Hashtag #SkinnyTok ist klar, dass Bodypositivity sich wieder aus dem Mainstream verabschiedet hat. Vorbei sind die Zeiten der Dove-Kampagnen, die Zeichen stehen wieder auf unverblümtes Fat-Shaming. Ehrlicherweise war Dünnsein nie „out“, aber zumindest hatte die Bodypositivity-Bewegung für eine Weile erreicht, Schönheitsstandards zu erweitern und sie generell zu hinterfragen. Das ging auch mit antirassistischen und anti-ableistischen Bewegungen einher. Doch jetzt machen wir dahingehend wieder Rückschritte. Weibliche Stars werden wieder dünner, Diätkultur ist überall. Wer nicht unendlich viel Protein isst und mindestens 10.000 Schritte am Tag läuft, hat sein Leben nicht im Griff – wird uns vermittelt. Dieser Wandel zurück zum Schlankheitsideal wird einerseits durch Medikamente wie Ozempic und Co. befeuert, andererseits geht er auch nicht zufällig mit dem Rechtsruck einher. Die Health-Bewegung ist mittlerweile von rechts vereinnahmt und wendet sich gegen die Wissenschaft (siehe „Make America Healthy Again“). Außerdem vermittelt Dünnsein unterschwellig eurozentristische, klassistische und binärgeschlechtliche Werte. In dieser Folge analysieren wir, wie wir wieder hierhin gekommen sind und was bei der Vermainstreamung der Bodypositivity-Bewegung schiefgelaufen ist.

TALK TO ME, TEXT ITWhat happens when we intentionally disconnect from the digital world? This intimate morning reflection explores the transformative power of putting down our phones and engaging with life directly.After becoming overwhelmed by online negativity and divisive discourse surrounding recent events, I made the decision to step away from social media for the weekend. What followed was a revelation in productivity and joy that many of us forget is possible in our hyper-connected lives. From quality family time at a newly discovered restaurant (The Flying Biscuit) to shopping excursions that took me slightly outside my comfort zone, the weekend became an exercise in rediscovering simple pleasures and accomplishment.The episode weaves personal experiences with broader observations about our relationship with technology and media consumption. I share book recommendations for "The Thursday Murder Club" series (far superior to the film adaptation), reveal fascinating trivia about the iconic boombox scene in "Say Anything," and discuss concerning research about Ozempic users abandoning their treatment regimens prematurely. Throughout these seemingly disparate topics runs a common thread – the value of mindfulness and presence in a world constantly competing for our attention.As we navigate increasingly complex and sometimes disturbing news cycles, including the recent incident in Utah where two men were arrested for planting an explosive device under a news van, perhaps the greatest self-care practice is knowing when to step back. Join me in exploring how periodic digital detoxes can help maintain our mental health while still staying informed about the world around us. What Bible verse brings you comfort during challenging times? Share your thoughts and join the conversation.Buzzsprout - Let's get your podcast launched!Start for FREE Thanks for listening! Liberty Line each week on Sunday, look for topics on my X file @americanistblog and submit your 1-3 audio opinions to anamericanistblog@gmail.com and you'll be featured on the podcast. Buzzsprout - Let's get your podcast launched!Start for FREESupport the showTip Jar for coffee $ - Thanks Music by Alehandro Vodnik from Pixabay Blog - AnAmericanist.comX - @americanistblog

Have you heard about people buying weight loss medications from unregulated sources online? The rise of black market weight loss drugs is putting lives at risk. In this episode, I discuss the concerning trend of people purchasing Retatrutide—a medication still in clinical trials—through illegal channels. Known as the "Godzilla Jab" for its potential power, early studies suggest this drug could help people lose up to 24% of their body weight. I explain what Retatrutide is and how it compares to FDA-approved medications like Ozempic, Wegovy, Zepbound, and Mounjaro. We explore why people take dangerous risks with black market drugs, from social media hype to cost concerns and access issues. Most importantly, I share the serious health and legal risks of buying unregulated medications and provide clear guidelines for safely accessing weight loss treatments through licensed providers. Tune in to learn how to protect yourself and make informed decisions about weight loss medications the safe way.   Episode Highlights: What is Retatrutide The dangers of purchasing unregulated medications online Factors driving people to illegal sources Legal risks of buying unapproved drugs and potential health complications from unregulated substances Safe Medication Practices Understanding that medication works best when combined with healthy eating, physical activity, adequate rest, and emotional support   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

The Dark Side of Ozempic From the Archives: Episode 313 Time-travel with us to a past episode where we dive into the rise of Ozempic for weight loss and what it means for both patients and dental professionals. Originally designed to manage type 2 diabetes, Ozempic's surge in popularity as a weight loss aid has sparked shortages and concerns for those who truly need it. We also explore side effects like digestive issues and halitosis that can show up in the dental chair. Rediscover this eye-opening episode and get the honest scoop on the promises and pitfalls of today's most talked-about weight loss drug. Connect with Tom Viola Website https://www.tomviola.com/ Facebook https://www.facebook.com/PharmacologyDeclassified LinkedIn https://www.linkedin.com/in/pharmacologydeclassified/ —-------------------------------------------- Hey friends—cool news! The Dental Assistant Nation Podcast was featured on Feedspot's Top 100 Dental Podcasts and their Top Dental Assistant Podcasts list. Huge thanks to you for listening, subscribing, and supporting the show. Couldn't have done it without you. Go check it out—we're listed alongside some amazing shows! 100 Best Dental Podcasts - https://podcast.feedspot.com/dental_podcasts/ 4 Best Dental Assistant Podcasts - https://podcast.feedspot.com/dental_assistant_podcasts/

Ozempic may be trending for weight loss, but the truth is it often leads to muscle loss, rebound weight gain, and hormonal chaos.  In this episode, Ben Azadi reveals how your body already has a built-in Ozempic system—and how to activate it naturally. You'll learn: Why Ozempic weight loss isn't real fat loss The 5 foods that naturally boost GLP-1 (your body's appetite-regulating hormone) The Better Than Ozempic Protocol for sustainable fat loss and muscle preservation How fasting, fermented foods, apple cider vinegar, and bitter-rich foods rewire your metabolism

Should sobriety be earned rather than prescribed?This week Vic and Hamish tackle the hype around Ozempic, the so-called miracle jab that claims to melt away kilos and even dampen alcohol cravings.It sounds tempting, right? But is it really the answer, or just another shiny shortcut that sidesteps the real work sobriety demands - you know, the uncomfortable, icky but rewarding bits like sitting with cravings, unravelling old habits, and actually dealing with what drove us to drink in the first place?They dig into the science, side effects, and sketchy unknowns, questioning whether reducing cravings with a drug is the same as actual long-term recovery. Along the way they share their own experiences, from resisting “easy fixes” to why the messy, imperfect slog of sobriety might be the most empowering path of all.Oh, and there is also a rather long monologue at the start of this episode about constipation.Expect a mix of laughs, some chat about odd bodily functions, a rather annoying Oscar level speech, and a shark teeth story.

First: a look ahead to President Trump's state visit next weekTransatlantic tensions are growing as the row over Peter Mandelson's role provides an ominous overture to Donald Trump's state visit next week. Political editor Tim Shipman has the inside scoop on how No. 10 is preparing. Keir Starmer's aides are braced for turbulence. ‘The one thing about Trump which is entirely predictable is his unpredictability,' one ventures. And government figures fear he may go off message on broadcast – he is scheduled to be interviewed by GB News.It is rare for leaders to receive a second visit, especially those in their second term. But, as Tim says, ‘Britishness is fashionable in Washington' and no-one likes ‘royal treatment' more than Trump. So, can Starmer take advantage of the President's ‘love of the deal'? Tim joins the podcast to discuss.Next: why are historical figures being labelled neurodiverse?A new biography of Margaret Thatcher has provoked much discussion by claiming that Britain's former Prime Minister was autistic. The proof for such a claim rests on the Iron Lady's (supposed) lack of a sense of humour, a lack of feeling embarrassed and a tendency to see the world in black and white. But is there a danger in reappraising historical and political figures, particularly when it comes to personal traits? Historians – and frequent Spectator contributors – Robert Tombs and John Keiger joined the podcast to give their verdict.And finally: is everyone on Ozempic?One of the Spectator's writers, under the pseudonym Henrietta Harding, headed out on what she terms ‘Ozempic safari' – spotting the ‘Mounjaro Mummies' as they drop off their children at school. ‘We know what to look for', she says, ‘sunken faces, slightly wasted arms and, of course, envy-inducing weight loss'.But the school gates aren't the only place Ozempic seems to have taken hold. Westminster is awash with politicians who have suspiciously slimmer fitting suits – but why? Associate editor Toby Young and deputy political editor James Heale join the podcast to make sense of the trend for trim.Plus: As President Xi re-emerges, Francis Pike asks who's really in charge in China?Hosted by William Moore and Lara Prendergast.Produced by Patrick Gibbons and Oscar Edmondson. Hosted on Acast. See acast.com/privacy for more information.

we discovered something very empowering this episode, and that is painting our faces as clowns. something about it made us feel invincible and intimidating muahahah. but in our clown getup, we got to chatting about gael's worst fear (eating a dozen crumble cookies), the ozempic boom, and why we hate coffee raves. follow us: @grownkld @gaelaitor@_kaylasuarez join our social club: https://form.typeform.com/to/eBSho4lE overshare with us: grownkid.com About our Partners: GrownKid is made in partnership with Joy Coalition where purpose driven content meets powerful storytelling. From 13 reasons Why to Unprisoned, Joy Coalition projects are made to bridge generations and drive groundbreaking conversations. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's been interesting to see which celebrities are admitting and NOT admitting to using GLP-1 medications. Throw back to Ashley Simpson lip syncing on SNL - It makes Chris Rock's handling of “The Slap” even more impressive. Nerd Alert: Astronauts reveal dinner parties in space aren't so glamorous. We all have particular hugging styles, and they vary depending on our relationship with the person. Think twice before you take the video games away from your kids - it turns out it might be training them for success.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

Liam Hemsworth is now engaged, Frankie Muniz turned down hosting Saturday Night Live so he could meet his crush and Jon Cryer shares how much he was paid compared to Charlie Sheen for Two and a Half Men.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

¡ todos mentimos ! Porque lo hacemos ?

This week, Lauren and Michelle cozy up in the frunchroom to tackle a hot topic that's been everywhere: Ozempic and the culture of weight loss. From the societal pressures that keep showing up in our feeds to how this new wave of “quick fixes” is reshaping the conversation around body image, the sisters get candid about it all.But, in true Sister Project fashion, the convo doesn't stop there. Expect detours into celebrity product launches, tea trends (yes, we're sipping on that too), social media burnout, and even some makeup tips that Lauren swears by. Michelle brings her bookish side with a powerful trauma lit reading recommendation while Lauren stays true to her book loving genre and leans into some Stephen King.Sprinkled in are plenty of giggles, honest reflections, and cozy recommendations for your watchlist, bookshelf, and vanity.Don't forget: you can watch this conversation unfold in real time on YouTube. Cozy vibes hit different in the frunchroom.Hot Topics: The Mist (audiobook), Billy Joel: And So It Goes (documentary), and As Ever tea.Resources: Lizzie Selle StudioFollow Us!Shop our seasonal candle line!Check out our website!This episode is sponsored by Helping Hand.

This week we have something delicious for our BBLs. We're doing one big round juicy segment with our angel/tormentor Big Ron aka Ronald Young Jr.!!!!The topic? The Biggest Loser documentary Fit for TV. Which brings us to...

Send us a textWe've all heard about the dramatic weight-loss results from drugs like Ozempic®, Wegovy®, semaglutide, and tirzepatide, but what aren't you hearing about? In this episode of The Trillium Show, board-certified plastic surgeon Dr. Jason Hall explains the under-the-radar effects these GLP-1 medications can have on your face and skin, including accelerated volume loss, thinning, and changes to your skin's ability to rejuvenate itself.Dr. Hall breaks down:Why these drugs can dramatically change your skin qualityWhat treatments (fat transfer, fillers, lasers, etc.) may help combat this and their limitationsHow to protect your muscle mass and skin health if you're taking or considering GLP-1sIf you're curious about the real impact of GLP-1 medications on aging skin, this episode is a must-listen.

Morse code transcription: vvv vvv Chappell Roan, Charli XCX and Doja Cat images among Music Photography Awards nominees Real Tarzann US influencer Mike Holston investigated over wild croc wrestling Repair Shop presenter Jay Blades pleads not guilty to rape Greenwich and Kent announce merger to form super university Police should stop recording non crime hate incidents, says watchdog Anti Islamic biker gang members run security at deadly Gaza aid sites Remains of missing Jordan Moray from Cwmbach found after six years Contactless card payments could become unlimited under new plans Ozempic maker Novo Nordisk to cut 9,000 jobs Mandelson expresses tremendous regret over Epstein friendship

The shock success of GLP-1 treatments for obesity carries massive implications for wealthy societies and manufacturers Novo Nordisk and Eli Lilly alike. In this week's Viewsroom podcast, Breakingviews columnists discuss how this would-be jackpot has companies running to keep up. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices

First: a look ahead to President Trump's state visit next weekTransatlantic tensions are growing as the row over Peter Mandelson's role provides an ominous overture to Donald Trump's state visit next week. Political editor Tim Shipman has the inside scoop on how No. 10 is preparing. Keir Starmer's aides are braced for turbulence. ‘The one thing about Trump which is entirely predictable is his unpredictability,' one ventures. And government figures fear he may go off message on broadcast – he is scheduled to be interviewed by GB News.It is rare for leaders to receive a second visit, especially those in their second term. But, as Tim says, ‘Britishness is fashionable in Washington' and no-one likes ‘royal treatment' more than Trump. So, can Starmer take advantage of the President's ‘love of the deal'? Tim joins the podcast to discuss.Next: why are historical figures being labelled neurodiverse?A new biography of Margaret Thatcher has provoked much discussion by claiming that Britain's former Prime Minister was autistic. The proof for such a claim rests on the Iron Lady's (supposed) lack of a sense of humour, a lack of feeling embarrassed and a tendency to see the world in black and white. But is there a danger in reappraising historical and political figures, particularly when it comes to personal traits? Historians – and frequent Spectator contributors – Robert Tombs and John Keiger joined the podcast to give their verdict.And finally: is everyone on Ozempic?One of the Spectator's writers, under the pseudonym Henrietta Harding, headed out on what she terms ‘Ozempic safari' – spotting the ‘Mounjaro Mummies' as they drop off their children at school. ‘We know what to look for', she says, ‘sunken faces, slightly wasted arms and, of course, envy-inducing weight loss'.But the school gates aren't the only place Ozempic seems to have taken hold. Westminster is awash with politicians who have suspiciously slimmer fitting suits – but why? Associate editor Toby Young and deputy political editor James Heale join the podcast to make sense of the trend for trim.Plus: As President Xi re-emerges, Francis Pike asks who's really in charge in China?Hosted by William Moore and Lara Prendergast.Produced by Patrick Gibbons and Oscar Edmondson.Become a Spectator subscriber today to access this podcast without adverts. Go to spectator.co.uk/adfree to find out more.For more Spectator podcasts, go to spectator.co.uk/podcasts. Contact us: podcast@spectator.co.uk Hosted on Acast. See acast.com/privacy for more information.

GLP-1 drugs like Ozempic are proven effective for type 2 diabetes and weight management. Researchers are now exploring their potential to reduce heart, kidney, liver, and even Alzheimer's disease risks. But experts, including obesity specialist Dr. Sean Wharton, warn against off-label use. He breaks down the latest research and what the future might hold.For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Apple just unveiled the iPhone Air… for Apple, it's survival by a thousand features.Wizard of Oz at the Sphere is basically the metaverse… and the blockbuster of 2025.Ben & Jerry are calling for their namesake brand to be freed from Unilever.Plus, the hot new startup trend… is no shoes allowed in the office.$UL $AAPL $SPHRWant more business storytelling from us? Check out the latest episode of our new weekly deepdive show: The untold origin story of… The New York Yankees ⚾Subscribe to The Best Idea Yet: https://wondery.com/links/the-best-idea-yet/ to listen.NEWSLETTER:https://tboypod.com/newsletter OUR 2ND SHOW:Want more business storytelling from us? Check our weekly deepdive show, The Best Idea Yet: The untold origin story of the products you're obsessed with. Listen for free to The Best Idea Yet: https://wondery.com/links/the-best-idea-yet/NEW LISTENERSFill out our 2 minute survey: https://qualtricsxm88y5r986q.qualtrics.com/jfe/form/SV_dp1FDYiJgt6lHy6GET ON THE POD: Submit a shoutout or fact: https://tboypod.com/shoutouts SOCIALS:Instagram: https://www.instagram.com/tboypod TikTok: https://www.tiktok.com/@tboypodYouTube: https://www.youtube.com/@tboypod Linkedin (Nick): https://www.linkedin.com/in/nicolas-martell/Linkedin (Jack): https://www.linkedin.com/in/jack-crivici-kramer/Anything else: https://tboypod.com/ About Us: The daily pop-biz news show making today's top stories your business. Formerly known as Robinhood Snacks, The Best One Yet is hosted by Jack Crivici-Kramer & Nick Martell.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this episode of The Wright Report, we cover disturbing new video evidence from the North Carolina stabbing, the true state of Biden's job market, Trump's tariff battles heading to the Supreme Court, and global updates from Ukraine to Qatar, Norway, and the medical world. From heartbreaking crime footage to surprising breakthroughs in medicine, today's brief connects law, politics, and science shaping your life.   Full Video of North Carolina Stabbing Released: The shocking footage shows Ukrainian refugee Iryna Zarutska stabbed on a Charlotte light rail while bystanders failed to help for nearly a minute. Bryan calls it proof of “the state of this country.” Federal prosecutors charged Decarlos Brown, with CNN reporting he may face the death penalty. Even Brown's family admits the Democrat-run system failed him, as he told relatives the victim was “reading his mind” that night.   Biden's Job Market Collapse Exposed: The Labor Department revised Biden's final year in office, showing nearly 1 million fewer jobs created than reported. Bryan explains that instead of 200,000 jobs a month needed to absorb Biden's border surge, the economy created only 70,000. “The data show you can blame Joe Biden — and his open borders policies.”   Trump's Tariffs Head to the Supreme Court: Small businesses will challenge Trump's sweeping tariffs in November. Trump warned, “If allowed to stand, this Decision would literally destroy the United States of America.” Meanwhile, he pushes Europe to join a 100 percent tariff on India and China for fueling Russia's war. Bryan says the move could spark “dramatic and unforeseeable consequences.”   Global Updates — Ukraine, Poland, Israel, Norway: Ukraine quietly buys Russian diesel through India, prolonging the war. Russian drones crossed into Polish airspace near a NATO hub, raising fears of a Gulf of Tonkin–style incident. Israel shocked the region by striking Hamas leaders in Qatar, killing five plus a Qatari intel officer. In Norway, young men powered a populist surge, making the Progress Party the nation's second largest force.   Medical Breakthroughs in Arthritis, Addiction, and Cancer: UK scientists develop “smart cartilage” that senses arthritis flare-ups and releases drugs on demand. Swedish researchers discover Ozempic curbs cocaine cravings. And the University of Michigan finds that restricting amino acids in the diet slows glioblastoma brain cancer, giving hope where it's rare.   "And you shall know the truth, and the truth shall make you free." - John 8:32   Take your personal data back with Incogni! Get 60% off an annual plan at incogni.com/TWR and use code TWR at checkout.   Keywords: Iryna Zarutska North Carolina stabbing video, Decarlos Brown schizophrenia, Biden jobs report revision, Biden open borders job losses, Trump tariffs Supreme Court case, Trump 100 percent tariffs India China, Ukraine Russian diesel India, Russian drones Poland NATO, Israel strike Hamas Qatar, Norway Progress Party populist youth, UK smart cartilage arthritis, Ozempic cocaine addiction Sweden, glioblastoma diet amino acids University of Michigan

We discuss why Jameela Jamil's anti-GLP-1 sentiment is uninformed. Taylor Lorenz pissed off a bunch of content creators with her journalism. Tracie went to see Oasis and gives an update on her kidney stone surgery. And Rich tells Tracie about the The Cut's "We've Reached Peak Gay Sluttiness" article that got gay guys all up in arms.To access video episodes, bonus episodes and our premium series WAWU—we're currently covering The Osbournes (RIP Ozzy)—check out our Patreon.Pot Psych merch is available at Pipe Dreams, where there is a big sale on smoking accessories.Check out potential drama and our Diamond Girls on our Instagram. ★ Support this podcast on Patreon ★

In this episode, Mike addresses what's going on when someone knows what they need to do to reach their goals but they just aren't doing it. What's really going on here? Is it true they know what to do? Or is something missing? Tune into this episode to find out.------------------------------------------------Click here to apply for coaching!For some amazing resources and to be a part of a badass community, join our FB group HEREThe personality assessment is now available online! Click here to take the assessment and find out what your personality tells us about the way you should be training and eating.Take the assessment here!To learn more about Neurotyping, visit www.neurotypetraining.comFollow Mike on IG at @coach_mike_millner

Hoy tenemos Consultorio con el Dr. Fernando Pérez Galaz, Médico cirujano especialista en cirugía del aparato digestivo y cirugía bariátrica, y nos va a responder todas las dudas sobre los GLP-1, es decir el Ozempic, Wegovy, Mounjaro y otras marcas más. Hosted on Acast. See acast.com/privacy for more information.

Kaya just be yapping!!! From Black Excellence to Yt nosiness she tackles the shocking Catfish documentary on Netflix, Lady Gaga skipping that last concert but showing up to the awards, Andy Cohen on Ozempic, Love Island Games and gives you the schedule of what we will be watching (yes, you). Wanna be like me, Andy and your neighbor next door? Get your GLP1 $40 off at this link:https://l.instagram.com/?u=https%3A%2F%2Fapp.joinmochi.com%2Feligibility%3Futm_source%3Dinfluencers%26ptcode%3Doe522a&e=AT1WA-pyf0O6sJpck8KVTaKufUYOgZqRIq8t8BGuVKiQaHRr7oCedyDJ1aHUjNcRdMi0jgP0BDYbRqCteLZkNDzX_paeBrp8wWQFQ6gfifTyC9zDFOLLOW US ON INSTAGRAM HERESUBSCRIBE TO OUR PATREON HEREOH YEAH WE ON THREADS HEREWHAT? YOU WANT OUR FACEBOOK? I GOT YOU RIGHT HERE

Plus: A federal judge blocks President Trump from removing Lisa Cook from the Federal Reserve Board. And, Ozempic-maker Novo Nordisk cuts 9,000 jobs as weigh-loss drug competition bites. Kate Bullivant hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Is food addiction real — and what does it mean for you? In this episode of the Love Your Life Show, I talk with neuroscientist and New York Times bestselling author Dr. Susan Peirce Thompson, founder of Bright Line Eating. We talk about the surprising science behind food addiction. You will want to listen in and hear what she says about willpower and our brain chemistry.  We explore: - How dopamine and food cravings create compulsive eating patterns - Why certain brains are more susceptible to sugar and processed food addiction - The four “bright lines” that help people find freedom from dieting — not restriction - The pros and cons of GLP‑1 medications like Ozempic for sustainable weight loss If you've struggled with emotional eating, yo-yo dieting, or feeling “out of control” around food, this conversation will help you understand the brain science of weight loss. Even greater news? It will give you hope that freedom is possible. Listen now to shift how you see food, addiction, and yourself. If you liked this show, you'll like this one: Who's Running the Show? Your Adult or Your Child Brain? on Apple Podcast https://podcasts.apple.com/us/podcast/94-adult-brain/id1434429161?i=1000475156589 Who's Running the Show? Your Adult or Your Child Brain? On Spotify https://open.spotify.com/episode/3i1cf87rqHtZVAyBzJbUlm?si=-tq3h4NJRgGo6iDx51pDPA To find the food addiction quiz, the Bright Line books and how to connect with her further, click here

In her annual State of the Union address, European Commission president Ursula von der Leyen has told the European Parliament it needs to regain its independence and bolster its defence capabilities in a 'hostile' world. Also, Danish company Novo Nordisk, the maker of weight-loss drugs Wegovy and Ozempic, has announced plans to cut 9,000 jobs. And the British horse racing industry has gone on strike for the first time ever, in protest at proposed tax rises on bets placed on the sport. You can contact us on WhatsApp or send us a voicenote: +44 330 678 3033.

If you've been hearing all the buzz about GLP-1 medications like Ozempic, Wegovy, or Zepbound, and you're wondering if they could be the right fit for you at midlife, this is the episode to press play on. We brought on nurse practitioner and health optimization expert Amy Wrenn to demystify what GLP-1s actually are, how they work, who they're for, and what you really need to know about taking them during perimenopause and menopause. Amy is passionate, informed, and totally relatable—she cuts through the hype to bring clarity to a topic that's been wrapped in confusion and judgment.In this conversation, we get real about our own experiences, bust some myths, talk side effects (yep, we go there), and explore the broader context of hormone therapy, weight gain, metabolic dysfunction, and the importance of doing what works for your individual body and life. Whether you're curious, cautious, or already on a GLP-1, this is a must-listen packed with valuable insights.  Episode Highlights:[0:00] - Welcoming Amy Wrenn and kicking off our deep dive into GLP-1s [3:10] - What exactly are GLP-1s, and how do they work in your body? [5:00] - Understanding insulin resistance, perimenopause, and why midlife changes everything [6:57] - Real-life examples of "metabolic mayhem" that hits out of nowhere [8:03] - Challenging the lazy stereotype: GLP-1s are not a quick fix [10:08] - The far-reaching benefits: inflammation, PCOS, cognitive health, and more [12:10] - Social media hype vs. safe medical prescribing—know the difference [13:46] - Compounded medications vs. name-brand prescriptions: what to watch for [17:33] - Who qualifies for GLP-1s, and what do providers look for? [20:43] - It's not about skinny—it's about healthy: the real goal of treatment [22:34] - Common side effects: what to expect and how to manage them [25:25] - Nutrition matters: prioritizing protein, avoiding high-fat traps [26:38] - Surprising benefits: reduced alcohol cravings, better food boundaries [28:12] - Coming off GLP-1s: what it looks like, and when it's okay to stay on [31:48] - Does your body adapt over time? Amy explains habituation and dosing [33:32] - The power trio: GLP-1s, HRT, and resistance training [36:08] - Hormone therapy explained: symptom relief vs. long-term prevention [40:51] - Why we're not getting this info from our doctors—and how to change that [42:24] - Where to follow Amy and keep learning more  Links & ResourcesFollow Amy Wrenn, NP on Instagram: https://www.instagram.com/np_wrenn If today's discussion resonated with you or sparked curiosity, please rate, follow, and share "Insights from the Couch" with others. Your support helps us reach more people and continue providing valuable insights. Here's to finding our purposes and living a life full of meaning and joy. Stay tuned for more!Come hang out with us in The Chat, our free community for midlife women, where we keep theconversation going at insightsfromthecouch.org/the-chat. And don't forget todownload our free guide 7 Skills to Master Midlife so you can stop living small, start taking action, andlive the life you really want at insightsfromthecouch.org/midlife-roadmap.

Get the Peptide Dosing download FREE and buy Peptides for 15% off! Go deeper with our Peptide Power course! 1 week VIP Tribe included with LIVE support from me! Get Your FREE Dosing Download, Buy Peptide Power Course & Join our VIP Tribe  --->DianeKazer.com/PEPTIDES 

Send us a textWhat really keeps people sober: faith, science, or a mix of both?In this episode of the Sober Friends Podcast, Matt and Steve dive into the tension—and surprising overlap—between faith-based recovery in AA and evidence-based approaches like therapy, medication, and new medical research. Matt shares a personal struggle with restless legs and sleep issues, along with his journey using weight loss medication, which sparks a bigger conversation: Can science offer the same kind of hope and healing that prayer and spirituality do?From GLP-1 drugs like Ozempic, to meditation, to the evolving role of AA in modern recovery, this episode explores whether sobriety is best rooted in faith, science, or some combination of the two.If you've ever wondered whether the future of recovery looks more like a Big Book or a lab report, this conversation is for you.Love the show? Stay connected between episodes with the Sober Friends Dispatch—our Substack newsletter packed with real stories, honest reflections, and tools to help you live your best sober life.

Every day we take a breath from our busy work day to get a break and hang out with friends and talk about the world of Sports, Entertainment and specifically CrossFit.  Today we discuss my Beloved Chicago Bears taking one on the chin, Alex Gazan takes a step back from TYR Wodapalooza So Cal, who should be her replacement?  Has CrossFit found its new enemy in GLP-1's?

Submit your question and we'll answer it in a future episode!Join our Patreon Community!https://www.patreon.com/badassbreastfeedingpodcastAre you planning to travel with your breastmilk? How do you even travel withbreastmilk? Can you fly with it or is it better to drive? Listen in today as Dianneand Abby break it all down, with the help of a Badass listener.If you are a new listener, we would love to hear from you.  Please consider leavingus a review on iTunes or sending us an email with your suggestions and commentsto badassbreastfeedingpodcast@gmail.com. You can also add your email to ourlist and have episodes sent right to your inbox!Things we talked about:Shout out to Puerto Rico [5:50]The travel email [10:10]Dry ice and flying [15:13]TSA rules for flying [24:28]Traveling is stressful [33:13]Milk Stork [33:34]Links to information we discussed or episodes you should check out!https://badassbreastfeedingpodcast.com/episode/102-pumping-and-traveling-with-breast-milk/https://badassbreastfeedingpodcast.com/episode/2790/Set up your consultation with Diannehttps://badassbreastfeedingpodcast.com/consultations/Check out Dianne's blog here:https://diannecassidyconsulting.com/milklytheblog/Follow our Podcast:https://badassbreastfeedingpodcast.comHere is how you can connect with Dianne and Abby:AbbyTheuring ,https://www.thebadassbreastfeeder.comDianne Cassidy @diannecassidyibclc, http://www.diannecassidyconsulting.comMusic we use:Music: Levels of Greatness from We Used to Paint Stars in the Sky (2012)courtesy of Scott Holmes at freemusicarchive.org/music/Scott Holmes